13.10011.73% ( -1.740 )
Closed: Nov 13, 16:00:00 (EDT)Profile
About

Iambic Therapeutics
IAM.US
Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc.
Profile
- Company Name
- Iambic Therapeutics, Inc.
- Market
- NasdaqGS
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- www.iambic.ai
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
